Drug Profile
SP 259
Alternative Names: SP-2-59Latest Information Update: 03 Aug 2021
Price :
$50
*
At a glance
- Originator Shuttle Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action HDAC6 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer